2927 — AFC-HD AMS Life Science Co Balance Sheet
0.000.00%
- ¥12bn
- ¥24bn
- ¥30bn
- 41
- 88
- 84
- 84
Annual balance sheet for AFC-HD AMS Life Science Co, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 4,726 | 9,222 | 10,378 | 11,182 | 12,173 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,128 | 2,184 | 2,563 | 2,828 | 2,814 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,009 | 15,852 | 17,125 | 19,875 | 22,095 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,659 | 16,012 | 15,923 | 17,145 | 19,416 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 18,549 | 35,752 | 37,349 | 41,072 | 47,031 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6,204 | 11,802 | 13,219 | 14,854 | 17,622 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 8,085 | 23,835 | 24,910 | 27,963 | 33,097 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 10,464 | 11,918 | 12,439 | 13,109 | 13,934 |
Total Liabilities & Shareholders' Equity | 18,549 | 35,752 | 37,349 | 41,072 | 47,031 |
Total Common Shares Outstanding |